6,699
Views
6
CrossRef citations to date
0
Altmetric
Commentary and View

A review of drug therapy for sporadic fatal insomnia

, &
Pages 293-299 | Received 25 May 2017, Accepted 14 Aug 2017, Published online: 12 Oct 2017

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Runcheng He, Yacen Hu, Lingyan Yao, Yun Tian, Yafang Zhou, Fang Yi, Lin Zhou, Hongwei Xu & Qiying Sun. (2019) Clinical features and genetic characteristics of two Chinese pedigrees with fatal family insomnia. Prion 13:1, pages 116-123.
Read now

Articles from other publishers (5)

Diana G. Sami & Mohamed Salama. 2023. Handbook of Neurodegenerative Disorders. Handbook of Neurodegenerative Disorders 1 53 .
Adam Tsou, Po-Jui Chen, Kuo-Wang Tsai, Wan-Chung Hu & Kuo-Cheng Lu. (2022) THαβ Immunological Pathway as Protective Immune Response against Prion Diseases: An Insight for Prion Infection Therapy. Viruses 14:2, pages 408.
Crossref
Cao Chen & Xiaoping Dong. (2021) Therapeutic implications of prion diseases. Biosafety and Health 3:2, pages 92-100.
Crossref
Younggi Choi & Brian K. Raymer. (2019) Sleep modulating agents. Bioorganic & Medicinal Chemistry Letters 29:16, pages 2025-2033.
Crossref
Anne M. Fink, Ulf G. Bronas & Michael W. Calik. (2018) Autonomic regulation during sleep and wakefulness: a review with implications for defining the pathophysiology of neurological disorders. Clinical Autonomic Research 28:6, pages 509-518.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.